Dare Bioscience, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Dare Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $166.70K, a 64.91% decline year-over-year.
- Dare Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $94.89K, a 78.25% decline year-over-year.
- Dare Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $18.74M.
- Dare Bioscience, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $475.01K, a 159.60% increase year-over-year.
- Dare Bioscience, Inc. stock issued during period, value, new issues for fiscal 2025 was $20.75M, a 4474.78% increase from fiscal 2024.
- Dare Bioscience, Inc. stock issued during period, value, new issues for fiscal 2024 was $453.58K, a 95.15% decline from fiscal 2023.
- Dare Bioscience, Inc. stock issued during period, value, new issues for fiscal 2023 was $9.35M, a 666.91% increase from fiscal 2022.
- Dare Bioscience, Inc. stock issued during period, value, new issues for fiscal 2022 was $1.22M, a 98.38% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $166.70K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $94.89K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $20.75M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $18.74M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $475.01K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $436.25K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $453.58K 10-K · filed 2026-03-26 | |
| 2024-06-30 | $182.98K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $215.11K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $9.35M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.11M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $452.19K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $1.30M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $1.22M 10-K · filed 2023-03-30 | |
| 2022-06-30 | $1.22M 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $75.31M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $35.01M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $13.25M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $11.32M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $22.98M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $5.28M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $4.02M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $5.22M 10-Q · filed 2021-11-10 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2019-06-30 | $5.15M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | -$2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $734.24K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$3.46K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | |
| 2018-03-31 | $9.16M 10-Q · filed 2019-05-14 | |
| 2014-12-31 | $59.86M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |